TG Therapeutics (NKB2) Cash flow

3 Followers

TG Therapeutics Cash Flow

DE:NKB2's free cash flow for Q2 2026 was $38.97M. For the 2026 fiscal year, DE:NKB2's free cash flow was decreased by $15.58M and operating cash flow was $39.26M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -24.77M	$ -40.52M	$ -31.41M	$ -176.17M	$ -295.63M
Investing Cash Flow	$ 13.80M	$ -1.04M	$ -50.65M	$ -20.01M	$ -332.00K
Financing Cash Flow	$ -89.73M	$ 128.53M	$ 72.70M	$ -391.00K	$ 41.42M
End Cash Position	$ 80.49M	$ 181.19M	$ 94.22M	$ 103.58M	$ 300.15M
Free Cash Flow	$ -24.99M	$ -40.56M	$ -31.41M	$ -176.18M	$ -296.04M

Currency in USD